Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-19T08:42:18.214Z Has data issue: false hasContentIssue false

An Heidenhain variant of the Creutzfeldt–Jakob disease misdiagnosed as a DSM-5 conversion disorder: a case report

Published online by Cambridge University Press:  06 May 2020

Abd El Kader Ait Tayeb*
Affiliation:
Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, France MOODS Team, CESP, Inserm, Faculté de Médecine, Université Paris-Saclay, UVSQ, Essonne, France
Rana Saad
Affiliation:
Service d’Ophtalmologie de Bicêtre, Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hôpitaux de Paris, DHU Vision et Handicaps, CRMR OPHTARA, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
Antoine Rousseau
Affiliation:
Service d’Ophtalmologie de Bicêtre, Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hôpitaux de Paris, DHU Vision et Handicaps, CRMR OPHTARA, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
Eric Deflesselle
Affiliation:
MOODS Team, CESP, Inserm, Faculté de Médecine, Université Paris-Saclay, UVSQ, Essonne, France Département de Médecine Générale, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France
Emmanuelle Duron
Affiliation:
MOODS Team, CESP, Inserm, Faculté de Médecine, Université Paris-Saclay, UVSQ, Essonne, France Service de Gériatrie, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France
Christian Denier
Affiliation:
Service de Neurologie de Bicêtre, Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
Denis Ducreux
Affiliation:
Service de Neuroradiologie de Bicêtre, CNRS IR4M, UMR 808, Hôpitaux Universitaires Paris Sud, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, France
Romain Colle
Affiliation:
Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, France MOODS Team, CESP, Inserm, Faculté de Médecine, Université Paris-Saclay, UVSQ, Essonne, France
Emmanuelle Corruble
Affiliation:
Service Hospitalo-Universitaire de Psychiatrie de Bicêtre, Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Le Kremlin Bicêtre, France MOODS Team, CESP, Inserm, Faculté de Médecine, Université Paris-Saclay, UVSQ, Essonne, France
*
Author for correspondence: Abd El Kader Ait Tayeb, Email: abdelkader.aittayeb@aphp.fr
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© The Author(s) 2020. Published by Cambridge University Press

To the Editor:

A 56-year-old outpatient of the ophthalmology department was referred to the liaison psychiatry team for blurred vision and transient blindness without a found somatic etiology. There was no specific personal medical history excepted an alcohol addiction.

The patient was first referred to the ophthalmology department 2 months after the symptom onset. At this time, the visual acuity, the optical coherence tomography, the retinal nerve fiber layer, and the ganglion cell layer complex (which excluded a glaucoma) were normal. But the Goldmann visual field testing, which is a subjective test, showed a transient lateral homonymous hemianopsia (LHH).

Thus, the patient was hospitalized in the neurology department. The EEG revealed a focal slowing in the bi-occipital region. The cerebral MRI (fluid-attenuated inversion recovery (FLAIR)-weighted images) evidenced nonspecific cortical hyperintensities which were not associated with the transient LHH. The Montreal Cognitive Assessment scored 19/30 which is in favor of cognitive dysfunction but was initially related to alcohol consumption. A functional etiology was then proposed by neurologists for this transient blurred vision.

Four months after the first consultation, the patient experienced a worsening of the eyesight with a total binocular blindness. Since visual acuity changed within minutes from light perception to a 20/20 score, the neurologist and ophthalmologist suggested the DSM-5 diagnosis of acute conversion disorder with visual symptoms and the patient was referred to the liaison psychiatry team. The examination evidenced a mild sadness and anxiety related to his medical condition and visual hallucinations. No anorexia, no insomnia, no suicidal thoughts, no athymhormia, no anhedonia, no other symptoms of an affective or a psychotic disorder and no symptoms of withdrawal delirium were evidenced. Fluctuating symptoms were observed, from accurate descriptions of the room to incapacity to describe the surroundings. No specific stress factor and no clear evidence for a functional disorder were identified. Of note, the patient did not meet all criteria for conversion symptoms of the Diagnostic Criteria for Psychosomatic Research (DCPR).Reference Cosci and Fava1

After a multidisciplinary staff, a second cerebral MRI with diffusion-weighted acquisition was prescribed because the psychiatric examination and paraclinical abnormalities (EEG and cerebral MRI) suggested a diagnosis of medical condition rather than a diagnosis of conversion disorder. The second MRI evidenced diffusion-weighted bi-occipital and parietal hyperintensities with a low Attenuated Diffusion Coefficient and FLAIR hyperintensities in the same areas suggesting an encephalopathy.

The patient was immediately admitted to the neurology department. Ataxia and myoclonus appeared 2 days later, suggesting a Creutzfeldt–Jakob disease (CJD). A second EEG showed a worsened activity with diffuse slowing and monophasic periodic sharp wave complexes (1 Hz). The cerebrospinal fluid (CSF) 14-3-3 protein assay was weakly positive, and the CSF Neopterin level was in the usual concentration range. A probable sporadic CJD according to criteria of the Centers for Disease Control and Prevention (CDC), and, more specifically, the Heidenhain variant, was diagnosed.Reference Lueck, McIlwaine and Zeidler2 Ten days later, the patient died, and the brain anatomopathological examination could not be performed.

In line with this case, the inadequacy of the DSM-5 classification of somatic symptom and the presentation of the DCPR have been described previously.Reference Cosci and Fava1 We agree that those DSM-5 criteria have a limited clinical utility for conversion disorder, a disorder generally poorly known to practitioners.

Our case highlights that the DSM-5 conversion disorder criteria may induce overdiagnosis, especially in rare diseases, like the Creutzfeldt–Jakob disease, with uncommon clinical presentation. It also emphasizes that transient, inconsistent, or fluctuating neurological symptoms may not be functional, psychological, or psychiatric, but due to a neurological disease.

The CJD is a rare neurodegenerative disorder induced by the Scrapie Prion (PrPsc).Reference Lueck, McIlwaine and Zeidler2 It is often associated with prodromal psychiatric symptoms such as depressive, psychotic or anxiety symptoms, sleep disturbances, and abnormal behavior. The Heidenhain variant represents 20% of the sporadic cases of Creutzfeldt–Jakob disease.Reference Lueck, McIlwaine and Zeidler2 Its main symptoms are visual, such as disturbed perception of colors or structures, visual hallucinations, cortical blindness or visual field defects, associated with MRI abnormalities in the occipital area (occipital cortical ribbon). Its median survival time is 6 months. It has been reported that those symptoms could be transient.Reference Lueck, McIlwaine and Zeidler2

This case-report emphasizes that rare diseases, such as the Heidenhain variant of CJD, can have uncommon clinical presentations, like an atypical transient and inconsistent cortical blindness. Those presentations may mimic DSM-5 conversion disorder.Reference Espay, Aybek and Carson3 Their diagnosis requires a thorough and repeated multidisciplinary assessment, particularly with neurological clinical and para-clinical assessments, since specific abnormalities may not be identified at the beginning. For example, MRI changes, and mainly cortical ones, are frequently misinterpreted in early stages of CJD.Reference Carswell, Thompson and Lukic4

Even if there is no curative treatment for CJD to date, its delayed diagnosis has consequences for the patient and the family, in terms of quality of life, stigmatization, and appropriate palliative care treatment.

With the DSM-5 diagnostic criteria of conversion disorder, unlike DSM-IV, the lack of stress factor before the symptom onset does not exclude anymore the diagnosis of conversion disorder, which is one of the major changes.

This change allows to avoid passing over a diagnosis of conversion disorder in case of difficulties to identify a stressful life event during a brief and unique psychiatric assessment.Reference Espay, Aybek and Carson3 But this leads to a possible inadequate over-diagnosis of conversion disorder, as practitioners are often deficiently trained to its diagnosis, especially in patients with rare organic diseases with psychiatric features, like the CJD. Indeed, among outpatients with unexplained neurological symptoms, 18% are diagnosed as conversion disorder.Reference Stone, Carson and Duncan5 Under DSM-5 definition, almost all of them could be diagnosed as conversion disorder.Reference Cosci and Fava1

Conversion disorder over-diagnosis could induce a delayed diagnosis of nonpsychiatric diseases with inherent mortality and morbidity risks. We suggest using other criteria as the DCPR to assess conversion symptoms and to rethink DSM criteria take into account a stress factor preceding symptom onset.

Funding

This work received no specific grant from any funding agency, commercial or not-for-profit sectors.

Disclosure

The authors do not have anything to disclose.

References

Cosci, F, Fava, GA. The clinical inadequacy of the DSM-5 classification of somatic symptom and related disorders: an alternative trans-diagnostic model. CNS Spectr. 2016;21(4):310317.CrossRefGoogle ScholarPubMed
Lueck, CJ, McIlwaine, GG, Zeidler, M. Creutzfeldt–Jakob disease and the eye. II. Ophthalmic and neuro-ophthalmic features. Eye. 2000;14(3):291301.CrossRefGoogle ScholarPubMed
Espay, AJ, Aybek, S, Carson, A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75(9):11321141.CrossRefGoogle ScholarPubMed
Carswell, C, Thompson, A, Lukic, A, et al. MRI findings are often missed in the diagnosis of Creutzfeldt–Jakob disease. BMC Neurol. 2012;12(1):153CrossRefGoogle Scholar
Stone, J, Carson, A, Duncan, R, et al. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(10):28782888.CrossRefGoogle ScholarPubMed